Post-Cutoff

“We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the…”

OpenAI @OpenAIX

Archived text

We’ve acquired Orchestra Bio, a platform that helps biopharma teams coordinate the complex process of drug development.

Together, we’ll build on Rosalind, our AI models and tools for life sciences research, to streamline those operations and help new treatments reach patients sooner.

Welcome @ashokaraj_ and team!

https://openai.com/index/openai-to-acquire-orchestra-bio/

Source: x.com/OpenAI/status/2112607347688583586Archived 2026-10-21 via fxtwitter (unofficial).Counts: 677,095 views, 6,534 likes, 603 reposts, 422 replies (at fetch time)

Cited in

  1. Business 112 days after the cutoff

    OpenAI buys Orchestra Bio